238 related articles for article (PubMed ID: 26890117)
1. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds.
Mohamed MA; Ayyad RR; Shawer TZ; Abdel-Aziz AA; El-Azab AS
Eur J Med Chem; 2016 Apr; 112():106-113. PubMed ID: 26890117
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
Abdel Gawad NM; Georgey HH; Youssef RM; El-Sayed NA
Eur J Med Chem; 2010 Dec; 45(12):6058-67. PubMed ID: 21051122
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4(3H)quinazolinone analogues.
Al-Suwaidan IA; Abdel-Aziz AA; Shawer TZ; Ayyad RR; Alanazi AM; El-Morsy AM; Mohamed MA; Abdel-Aziz NI; El-Sayed MA; El-Azab AS
J Enzyme Inhib Med Chem; 2016; 31(1):78-89. PubMed ID: 25815668
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues.
El-Azab AS; Abdel-Aziz AA; Ghabbour HA; Al-Gendy MA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1229-1239. PubMed ID: 28948843
[TBL] [Abstract][Full Text] [Related]
6. Parallel solution phase synthesis of 3,6,7-4(3H)-quinazolinones and evaluation of their antitumor activities against human cancer.
Wu H; Xie X; Liu G
J Comb Chem; 2010 May; 12(3):346-55. PubMed ID: 20196566
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of quinazolin-4(3H)-one derivatives bearing dithiocarbamate side chain at C2-position as potential antitumor agents.
Ding PP; Gao M; Mao BB; Cao SL; Liu CH; Yang CR; Li ZF; Liao J; Zhao H; Li Z; Li J; Wang H; Xu X
Eur J Med Chem; 2016 Jan; 108():364-373. PubMed ID: 26703795
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies.
Alanazi AM; Abdel-Aziz AA; Shawer TZ; Ayyad RR; Al-Obaid AM; Al-Agamy MH; Maarouf AR; El-Azab AS
J Enzyme Inhib Med Chem; 2016 Oct; 31(5):721-35. PubMed ID: 26162029
[TBL] [Abstract][Full Text] [Related]
10. Potential anti-proliferative agents from 1,4-benzoxazinone-quinazolin-4(3H)-one templates.
Bollu R; Banu S; Kasaboina S; Bantu R; Nagarapu L; Polepalli S; Jain N
Bioorg Med Chem Lett; 2017 Dec; 27(24):5481-5484. PubMed ID: 29089233
[TBL] [Abstract][Full Text] [Related]
11. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
Huang WY; Zhang XR; Lyu L; Wang SQ; Zhang XT
Bioorg Chem; 2020 Jun; 99():103814. PubMed ID: 32278208
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition.
Yang H; Li Q; Su M; Luo F; Liu Y; Wang D; Fan Y
Bioorg Med Chem; 2021 Sep; 46():116346. PubMed ID: 34403956
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
Al-Rashood ST; Hassan GS; El-Messery SM; Nagi MN; Habib EE; Al-Omary FAM; El-Subbagh HI
Bioorg Med Chem Lett; 2014 Sep; 24(18):4557-4567. PubMed ID: 25139568
[TBL] [Abstract][Full Text] [Related]
14. Lemon Juice Mediated Synthesis of 3-Substituted Quinazolin-4(3H)-Ones and their Pharmacological Evaluation.
Prasad MG; Lakshmi CV; Katari NK; Jonnalagadda SB; Pal M
Anticancer Agents Med Chem; 2019; 19(16):2001-2009. PubMed ID: 31340741
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity evaluation of PI3K inhibitors containing 3-substituted quinazolin-4(3H)-one moiety.
Zhang H; Xin MH; Xie XX; Mao S; Zuo SJ; Lu SM; Zhang SQ
Bioorg Med Chem; 2015 Dec; 23(24):7765-76. PubMed ID: 26652969
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
Kamal A; Bharathi EV; Reddy JS; Ramaiah MJ; Dastagiri D; Reddy MK; Viswanath A; Reddy TL; Shaik TB; Pushpavalli SN; Bhadra MP
Eur J Med Chem; 2011 Feb; 46(2):691-703. PubMed ID: 21194809
[TBL] [Abstract][Full Text] [Related]
17. Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3H)-ones as CFM-1 analogs: design, synthesis, QSAR analysis and anticancer activity.
Alafeefy AM; Ashour AE; Prasad O; Sinha L; Pathak S; Alasmari FA; Rishi AK; Abdel-Aziz HA
Eur J Med Chem; 2015 Mar; 92():191-201. PubMed ID: 25555142
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold.
Mahdavi M; Pedrood K; Safavi M; Saeedi M; Pordeli M; Ardestani SK; Emami S; Adib M; Foroumadi A; Shafiee A
Eur J Med Chem; 2015 May; 95():492-9. PubMed ID: 25847767
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel 7-aminoquinazoline derivatives: antitumor and anticonvulsant activities.
El-Azab AS; Eltahir KE
Bioorg Med Chem Lett; 2012 Mar; 22(5):1879-85. PubMed ID: 22326394
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.
Fan YH; Li W; Liu DD; Bai MX; Song HR; Xu YN; Lee S; Zhou ZP; Wang J; Ding HW
Eur J Med Chem; 2017 Oct; 139():95-106. PubMed ID: 28800461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
